IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

TINERA DAWN HUTCHINS-CONRY

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1982089157
CMS profile
11174542
Location
MCMINNVILLE, TN

General Payments · PY2021–2024

$1,547.47

  • Reported across 111 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$714.25

50 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Family TN All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $714.25 50

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $281.20 28
Novo Nordisk AS $134.30 6
Janssen Pharmaceuticals, Inc $98.00 5
Boehringer Ingelheim Pharmaceuticals, Inc. $81.18 4
Acerta Pharma LLC $66.88 4
HEARTFLOW, INC. $18.78 1
Lexicon Pharmaceuticals, Inc. $17.80 1
SANOFI-AVENTIS U.S. LLC $16.11 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $281.08 34
PY2022 $132.11 3
PY2023 $420.03 24
PY2024 $714.25 50

Payment records · PY2024 (50)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $22.90 02/13/2024 Food and Beverage Undisputed 01/23/2026 1105664398 CMS
AstraZeneca Pharmaceuticals LP $16.18 03/08/2024 Food and Beverage Undisputed 01/23/2026 1104497966 CMS
AstraZeneca Pharmaceuticals LP $14.02 04/19/2024 Food and Beverage Undisputed 01/23/2026 1105630895 CMS
AstraZeneca Pharmaceuticals LP $13.78 08/07/2024 Food and Beverage Undisputed 01/23/2026 1105372297 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.09 04/24/2024 Food and Beverage Undisputed 01/23/2026 1118259519 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.95 06/06/2024 Food and Beverage Undisputed 01/23/2026 1118259515 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.56 07/10/2024 Food and Beverage Undisputed 01/23/2026 1118259517 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.58 08/15/2024 Food and Beverage Undisputed 01/23/2026 1118259513 CMS
HEARTFLOW, INC. $18.78 09/11/2024 Food and Beverage Undisputed 01/23/2026 1154178838 CMS
Janssen Pharmaceuticals, Inc $15.76 01/09/2024 Food and Beverage Undisputed 01/23/2026 1078186045 CMS
Janssen Pharmaceuticals, Inc $20.00 06/25/2024 Food and Beverage Undisputed 01/23/2026 1078186043 CMS
Janssen Pharmaceuticals, Inc $20.47 07/16/2024 Food and Beverage Undisputed 01/23/2026 1078186029 CMS
Janssen Pharmaceuticals, Inc $19.42 08/13/2024 Food and Beverage Undisputed 01/23/2026 1078186041 CMS
Janssen Pharmaceuticals, Inc $22.35 09/03/2024 Food and Beverage Undisputed 01/23/2026 1078186039 CMS
Lexicon Pharmaceuticals, Inc. $17.80 07/24/2024 Food and Beverage Undisputed 01/23/2026 1081730007 CMS
Novartis Pharmaceuticals Corporation $10.80 01/22/2024 Food and Beverage Undisputed 01/23/2026 1086808029 CMS
Novartis Pharmaceuticals Corporation $20.50 01/24/2024 Food and Beverage Undisputed 01/23/2026 1086808025 CMS
Novartis Pharmaceuticals Corporation $14.94 02/05/2024 Food and Beverage Undisputed 01/23/2026 1086808031 CMS
Novartis Pharmaceuticals Corporation $5.92 02/13/2024 Food and Beverage Undisputed 01/23/2026 1086808027 CMS
Novartis Pharmaceuticals Corporation $3.90 03/08/2024 Food and Beverage Undisputed 01/23/2026 1086808035 CMS
Novartis Pharmaceuticals Corporation $23.01 04/10/2024 Food and Beverage Undisputed 01/23/2026 1086808033 CMS
Novartis Pharmaceuticals Corporation $7.42 04/15/2024 Food and Beverage Undisputed 01/23/2026 1086808043 CMS
Novartis Pharmaceuticals Corporation $3.49 04/15/2024 Food and Beverage Undisputed 01/23/2026 1086808045 CMS
Novartis Pharmaceuticals Corporation $11.54 04/22/2024 Food and Beverage Undisputed 01/23/2026 1086808041 CMS
Novartis Pharmaceuticals Corporation $16.96 05/13/2024 Food and Beverage Undisputed 01/23/2026 1086808047 CMS
Novartis Pharmaceuticals Corporation $16.09 05/28/2024 Food and Beverage Undisputed 01/23/2026 1086808059 CMS
Novartis Pharmaceuticals Corporation $5.80 06/12/2024 Food and Beverage Undisputed 01/23/2026 1086808061 CMS
Novartis Pharmaceuticals Corporation $11.99 06/12/2024 Food and Beverage Undisputed 01/23/2026 1086808063 CMS
Novartis Pharmaceuticals Corporation $3.81 06/12/2024 Food and Beverage Undisputed 01/23/2026 1086808083 CMS
Novartis Pharmaceuticals Corporation $5.01 06/12/2024 Food and Beverage Undisputed 01/23/2026 1086808089 CMS
Novartis Pharmaceuticals Corporation $26.99 06/26/2024 Food and Beverage Undisputed 01/23/2026 1086808065 CMS
Novartis Pharmaceuticals Corporation $7.87 07/08/2024 Food and Beverage Undisputed 01/23/2026 1086808075 CMS
Novartis Pharmaceuticals Corporation $3.28 07/08/2024 Food and Beverage Undisputed 01/23/2026 1086808077 CMS
Novartis Pharmaceuticals Corporation $4.59 07/16/2024 Food and Beverage Undisputed 01/23/2026 1086808085 CMS
Novartis Pharmaceuticals Corporation $3.93 07/16/2024 Food and Beverage Undisputed 01/23/2026 1086808091 CMS
Novartis Pharmaceuticals Corporation $2.55 07/23/2024 Food and Beverage Undisputed 01/23/2026 1086808087 CMS
Novartis Pharmaceuticals Corporation $1.93 07/23/2024 Food and Beverage Undisputed 01/23/2026 1086808093 CMS
Novartis Pharmaceuticals Corporation $27.27 07/31/2024 Food and Beverage Undisputed 01/23/2026 1086808081 CMS
Novartis Pharmaceuticals Corporation $17.19 08/19/2024 Food and Beverage Undisputed 01/23/2026 1086808103 CMS
Novartis Pharmaceuticals Corporation $12.12 09/16/2024 Food and Beverage Undisputed 01/23/2026 1086808113 CMS
Novartis Pharmaceuticals Corporation $4.12 10/21/2024 Food and Beverage Undisputed 01/23/2026 1086808123 CMS
Novartis Pharmaceuticals Corporation $4.22 11/25/2024 Food and Beverage Undisputed 01/23/2026 1086808125 CMS
Novartis Pharmaceuticals Corporation $3.96 12/20/2024 Food and Beverage Undisputed 01/23/2026 1086808127 CMS
Novo Nordisk Inc $23.56 02/08/2024 Food and Beverage Undisputed 01/23/2026 1100309247 CMS
Novo Nordisk Inc $20.82 02/23/2024 Food and Beverage Undisputed 01/23/2026 1100460386 CMS
Novo Nordisk Inc $22.90 03/23/2024 Food and Beverage Undisputed 01/23/2026 1100287596 CMS
Novo Nordisk Inc $23.45 04/09/2024 Food and Beverage Undisputed 01/23/2026 1100631017 CMS
Novo Nordisk Inc $22.15 04/12/2024 Food and Beverage Undisputed 01/23/2026 1100281162 CMS
Novo Nordisk Inc $21.42 05/06/2024 Food and Beverage Undisputed 01/23/2026 1100372164 CMS
SANOFI-AVENTIS U.S. LLC $16.11 01/11/2024 Food and Beverage Undisputed 01/23/2026 1139959425 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.